{"id":187151,"date":"2022-09-25T23:51:23","date_gmt":"2022-09-26T06:51:23","guid":{"rendered":"https:\/\/lifesciences.csoftintl.com\/?p=187151"},"modified":"2022-09-26T18:39:56","modified_gmt":"2022-09-27T01:39:56","slug":"%e4%bf%84%e4%b9%8c%e6%88%98%e4%ba%89%e5%af%b9%e5%85%a8%e7%90%83%e5%b7%a5%e4%b8%9a%e4%b8%b4%e5%ba%8a%e8%af%95%e9%aa%8c%e7%9a%84%e5%bd%b1%e5%93%8d","status":"publish","type":"post","link":"https:\/\/lifesciences.csoftintl.com\/zh-hans\/blog\/%e4%bf%84%e4%b9%8c%e6%88%98%e4%ba%89%e5%af%b9%e5%85%a8%e7%90%83%e5%b7%a5%e4%b8%9a%e4%b8%b4%e5%ba%8a%e8%af%95%e9%aa%8c%e7%9a%84%e5%bd%b1%e5%93%8d\/","title":{"rendered":"\u4e34\u5e8a\u8bd5\u9a8c\u8bba\u575b\uff1a\u4fc4\u4e4c\u6218\u4e89\u5bf9\u5168\u7403\u5de5\u4e1a\u4e34\u5e8a\u8bd5\u9a8c\u7684\u5f71\u54cd"},"content":{"rendered":"

\"\"<\/p>\n

\u4e34\u5e8a\u8bd5\u9a8c\u7cfb\u5217\u7531LongTaal\u516c\u53f8\u521b\u59cb\u4eba\u3001CSOFT\u5168\u7403\u4e34\u5e8a\u6218\u7565\u526f\u603b\u88c1Vladimir Misik\u535a\u58eb\u521b\u529e\u3002<\/em><\/p>\n

\u6b63\u5982\u6211\u4ecb\u7ecd\u4e2d\u6240\u5199\uff0c\u8be5\u7cfb\u5217\u7684\u76ee\u7684\u662f\u4ecb\u7ecd\u548c\u5256\u6790\u4e34\u5e8a\u8bd5\u9a8c\u9886\u57df\u4ee5\u53ca\u76f8\u5173\u8bdd\u9898–\u533b\u836f\u4ea7\u54c1\u7684\u5f00\u53d1\u3002\u6587\u7ae0\u7684\u76ee\u7684\u4e0d\u662f\u5bf9\u6bcf\u4e2a\u4e3b\u9898\u8fdb\u884c\u5168\u9762\u7684\u56de\u987e\uff0c\u800c\u662f\u5411\u5927\u5bb6\u63d0\u4f9b\u6211\u7684\u4e2a\u4eba\u89c2\u70b9\u3002\u6bcf\u4e00\u4e2a\u597d\u7684\u4e13\u4e1a\u8ba8\u8bba\u90fd\u9700\u8981\u52aa\u529b\u8ffd\u6c42\u5ba2\u89c2\u6027\uff0c\u56e0\u6b64\u6211\u975e\u5e38\u6b22\u8fce\u5404\u79cd\u5bf9\u6240\u9009\u4e3b\u9898\u7684\u89c2\u70b9\u3002<\/p>\n

\u867d\u7136\u6211\u66f4\u503e\u5411\u4e8e\u7528\u4e00\u4e2a\u66f4\u4ee4\u4eba\u632f\u594b\u7684\u8bdd\u9898\u6765\u5f00\u59cb\u8fd9\u4e2a\u7cfb\u5217\uff0c\u4f46\u5982\u679c\u5ffd\u89c6\u8fd9\u4e2a\u8bdd\u9898\uff0c\u90a3\u5c06\u662f\u6211\u7684\u5931\u804c\uff0c\u4e0d\u4ec5\u56e0\u4e3a\u81ea2022\u5e742\u6708\u6218\u4e89\u5f00\u59cb\u4ee5\u6765\uff0c\u5b83\u4e00\u76f4\u5728\u5404\u4e3b\u6d41\u5a92\u4f53\u7684\u5934\u7248\u5934\u6761\uff0c\u800c\u4e14\u8fd8\u56e0\u4e3a\u5b83\u5bf9\u5168\u7403\u884c\u4e1a\u4e34\u5e8a\u8bd5\u9a8c\uff08iCTs\uff09\u4ea7\u751f\u4e86\u91cd\u5927\u4e0d\u5229\u5f71\u54cd\u3002\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u53ca\u65f6\u62db\u52df\u60a3\u8005\u662f\u65b0\u836f\u54c1\u7814\u53d1\u7684\u6700\u5927\u6311\u6218\u4e4b\u4e00\uff08\u672a\u6765\u51e0\u5468\u6211\u5c06\u7528\u4e00\u6574\u7bc7\u6587\u7ae0\u6765\u8ba8\u8bba\u8fd9\u4e2a\u8bdd\u9898\uff09\uff0c\u8fc4\u4eca\u4e3a\u6b62\uff0c\u4fc4\u7f57\u65af\u548c\u4e4c\u514b\u5170\u4e00\u76f4\u5728\u4e3aiCTs\u8d21\u732e\u4e86\u5f88\u5927\u6bd4\u4f8b\u7684\u5168\u7403\u62db\u52df\u60a3\u8005\u3002\u56e0\u6b64\uff0c\u8fd9\u4e9biCTs\u5e02\u573a\u7684\u4efb\u4f55\u91cd\u5927\u4e0d\u5229\u4e8b\u4ef6\u90fd\u5c06\u4e0d\u53ef\u907f\u514d\u5730\u5728\u6574\u4e2a\u884c\u4e1a\u4e2d\u6380\u8d77\u6d9f\u6f2a\u3002<\/p>\n

\u4fc4\u7f57\u65af\u5728\u4e4c\u514b\u5170\u53d1\u52a8\u7684\u6218\u4e89\u4e0d\u4ec5\u5bf9\u8fd9\u4e9b\u56fd\u5bb6\uff0c\u800c\u4e14\u5bf9\u5168\u7403\u7684iCTs\u90fd\u6709\u76f4\u63a5\u548c\u957f\u671f\u7684\u5f71\u54cd\uff0c\u56e0\u4e3a\u8fd9\u4e24\u4e2a\u56fd\u5bb6\u5728\u521b\u65b0\u751f\u7269\u5236\u836f\u516c\u53f8\u8fdb\u884c\u7684\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u5360\u6bd4\u5168\u7403\u76843.6%\uff0c\u4ee5\u53ca\u60a3\u8005\u6570\u91cf\u76845%\u3002<\/p>\n

\u5f80\u671f\u6587\u7ae0\u4e2d\u7684GlobalData\u6570\u636e\u663e\u793a\u4e86\u4fc4\u7f57\u65af\u7684iCTs\u60c5\u51b5\uff0c\u6982\u8ff0\u4e86\u8fd9\u4e9b\u4e0d\u5229\u4e8b\u4ef6\u53ef\u80fd\u5bf9\u4fc4\u7f57\u65af\u548c\u5168\u7403\u4ea7\u751f\u7684\u4e25\u91cd\u5f71\u54cd\u3002\u4ee5\u4e0b\u662f\u57fa\u4e8e\u7533\u529e\u65b9\u548c\u6cbb\u7597\u9002\u5e94\u75c7\u4e2d\u53d7\u5f71\u54cdCT\u7684\u6570\u91cf\u5f97\u51fa\u7684\u7ed3\u8bba\u3002[i]<\/a><\/p>\n

\u5728\u672c\u7bc7\u6587\u7ae0\u4e2d\uff0c\u6211\u4eec\u8fdb\u4e00\u6b65\u4f7f\u7528LongTaal \u5e73\u53f0\u63d0\u4f9b\u4fc4\u7f57\u65af\u5165\u4fb5\u4e4c\u514b\u5170\u65f6\u7684iCTs\u5feb\u7167\uff0c\u9884\u6d4b\u4e86\u5bf9\u4e24\u56fd\u4ee5\u53ca\u5168\u7403CTs\u7684\u6f5c\u5728\u5f71\u54cd\uff0c\u5e76\u6982\u8ff0\u4e86\u5bf9\u4e24\u56fd\u5c06\u9020\u6210\u7684\u66f4\u6df1\u8fdc\u7684\u793e\u4f1a\u7ecf\u6d4e\u5f71\u54cd\u3002[ii]<\/a><\/p>\n

\u5728\u6211\u5f00\u59cb\u4f7f\u7528\u4e00\u4e9b\u65b0\u7684\u672f\u8bed\uff08\u4f8b\u5982\uff0ciCT\u5e02\u573a\u4efd\u989d\u3001iCT\u7684\u53ef\u53ca\u6027\u6216\u53bf\u7ea7iCT\u58f0\u8a89\u6307\u6570\uff09\u5e76\u5f00\u59cb\u629b\u51fa\u4e00\u4e9b\u4e0e\u4e4b\u76f8\u5173\u7684\u6570\u5b57\u4e4b\u524d\uff0c\u9996\u5148\u8ba9\u6211\u4ecb\u7ecd\u6211\u4eec\u6700\u8fd1\u520a\u767b\u7684\u6587\u7ae0<\/a>\u2014\u5176\u4e2d\u89e3\u91ca\u4e86\u8fd9\u4e9b\u672f\u8bed\u548c\u83b7\u5f97\u8fd9\u4e9b\u672f\u8bed\u65f6\u4f7f\u7528\u7684\u6570\u636e\u6765\u6e90\u548c\u65b9\u6cd5\u3002[iii]<\/a><\/p>\n

\u9996\u5148\uff0c\u8ba9\u6211\u4eec\u6765\u8bc4\u4f30\u4e00\u4e0b\u6218\u4e89\u5bf9\u4e24\u56fd\u7684\u5f71\u54cd\u3002<\/p>\n

\u5bf9\u4fc4\u7f57\u65af\u4e34\u5e8a\u8bd5\u9a8c\u7684\u5f71\u54cd\uff1a<\/strong><\/p>\n

2022\u5e742\u670824\u65e5\uff0c\u5f53\u4fc4\u7f57\u65af\u5165\u4fb5\u4e4c\u514b\u5170\u65f6\uff0c\u4fc4\u7f57\u65af\u572810158\u4e2a\u4e34\u5e8a\u8bd5\u9a8c\u70b9\u67091243\u4e2a\u6d3b\u8dc3\u7684CT\u6b63\u5728\u8fdb\u884c\u30022021\u5e74\uff0c\u4fc4\u7f57\u65af\u5728\u5168\u7403\u751f\u7269\u5236\u836fCT\u5e02\u573a\u4efd\u989d\u65b9\u9762\u6392\u540d\u7b2c11\u4f4d\uff082.44%\uff09\uff0c\u80bf\u7624\u5b66\u662f\u6700\u4e3b\u8981\u7684\u6cbb\u7597\u9886\u57df\u3002<\/p>\n

\u897f\u65b9\u56fd\u9645iCT\u8d5e\u52a9\u8005\u5bf9\u4fc4\u7f57\u65afiCT\u7684\u8d21\u732e\u7ea6\u536090%\u3002\u867d\u7136\u51fa\u4e8e\u9053\u5fb7\u539f\u56e0\uff0c\u6d3b\u4f53\u4fdd\u5b58\u548c\u836f\u54c1\u7684\u51fa\u53e3\u4e0d\u5c5e\u4e8e\u5236\u88c1\u8303\u56f4\uff0c\u4f46\u6240\u6709\u5927\u578b\u7684\u5236\u836f\u516c\u53f8\u51e0\u4e4e\u90fd\u5ba3\u5e03\u505c\u6b62\u5728\u4fc4\u7f57\u65af\u7684\u65b0\u6295\u8d44\uff0c\u5305\u62ec\u4e34\u5e8a\u8bd5\u9a8c[iv]<\/a>\uff0c\u5e76\u4e14\u505c\u6b62\u4e3a\u6b63\u5728\u8fdb\u884c\u7684CT\u62db\u52df\u65b0\u60a3\u8005\uff0c\u5e76\u627f\u8bfa\u4e0d\u5728\u4fc4\u7f57\u65af\u53d1\u8d77\u65b0\u7684\u8bd5\u9a8c\u3002\u56e0\u6b64\uff0c\u5728\u672a\u6765\u4e09\u5e74\u5185\uff0c\u9884\u8ba1iCT\u6d3b\u52a8\u5c06\u6bd4\u6218\u524d\u6c34\u5e73\u51cf\u5c11\u8fd190%\uff08\u6216\u5168\u7403iBPCT\u5e02\u573a\u4efd\u989d\u51cf\u5c112.2%\uff09\uff0c\u5bfc\u81f4\u6bcf\u5e74\u7ecf\u6d4e\u4ef7\u503c\u635f\u5931\u8d85\u8fc712\u4ebf\u7f8e\u5143\uff0ciBPCT\u884c\u4e1a\u521b\u9020\u7684\u8fd18000\u4e2a\u9ad8\u7aef\u5de5\u4f5c\u5c97\u4f4d\u6d41\u5931\uff0c\u6bcf\u5e74\u6709\u8d85\u8fc73\u4e07\u540d\u60a3\u8005\u5931\u53bb\u83b7\u5f97\u5c16\u7aef\u5b9e\u9a8c\u7597\u6cd5\u7684\u673a\u4f1a\u3002<\/p>\n

\u9274\u4e8e\u897f\u65b9iCTs\u8d5e\u52a9\u5546\u5728\u4fc4\u7f57\u65afCT\u5e02\u573a\u7684\u538b\u5012\u6027\u4efd\u989d\uff0c\u8be5\u5e02\u573a\u635f\u5931\u4e0d\u592a\u53ef\u80fd\u7531\u4fc4\u7f57\u65af\u3001\u4e2d\u56fd\u548c\u5370\u5ea6\u7684\u516c\u53f8\u6765\u5f25\u8865\uff0c\u56e0\u4e3a\u8fd9\u4e9b\u516c\u53f8\u4e3b\u8981\u662f\u751f\u4ea7\u975e\u4e13\u5229\u5316\u5408\u7269\uff0c\u5e76\u4e14\u53ea\u5360\u5168\u7403\u751f\u7269\u5236\u836f\u7814\u53d1\u603b\u652f\u51fa\u7684\u4e00\u5c0f\u90e8\u5206\u3002<\/p>\n

\u5bf9\u4e4c\u514b\u5170\u4e34\u5e8a\u8bd5\u9a8c\u7684\u5f71\u54cd\uff1a<\/strong><\/p>\n

\u4e4c\u514b\u5170\u7684iCT\u5e02\u573a\u89c4\u6a21\u5927\u7ea6\u662f\u4fc4\u7f57\u65af\u7684\u4e00\u534a\u3002\u5f53\u6218\u4e89\u5f00\u59cb\u65f6\uff0c\u4e4c\u514b\u5170\u76845015\u4e2a\u4e34\u5e8a\u8bd5\u9a8c\u70b9\u5927\u7ea6\u6709612\u9879\u6d3b\u8dc3\u7814\u7a76\u6b63\u5728\u8fdb\u884c\u30022021\u5e74\uff0c\u4e4c\u514b\u5170\u5728\u5168\u7403\u751f\u7269\u5236\u836fCT\u5e02\u573a\u4efd\u989d\u65b9\u9762\u6392\u540d\u7b2c18\u4f4d\uff0c\u5360\u5168\u7403\u4efd\u989d\u76841.18%\uff0c\u80bf\u7624\u5b66\u5728\u6cbb\u7597\u9886\u57df\u4e2d\u5360\u4e3b\u5bfc\u5730\u4f4d\u3002<\/p>\n

\u5bf9\u4e8e\u4e4c\u514b\u5170\u800c\u8a00\uff0c\u6218\u4e89\u7684\u77ed\u671f\u548c\u4e2d\u671f\u5f71\u54cd\u5c06\u4e0e\u4fc4\u7f57\u65af\u76f8\u4f3c\uff1a\u7531\u4e8e\u6218\u4e89\u7684\u5e72\u6270\uff0c\u5927\u591a\u6570\u7533\u529e\u65b9\u5df2\u7ecf\u505c\u6b62\u62db\u52df\u65b0\u7684\u60a3\u8005\u52a0\u5165\u6b63\u5728\u8fdb\u884c\u7684CTs\uff0c\u5e76\u6682\u505c\u542f\u52a8\u65b0\u7684CTs\u3002\u53ea\u8981\u5b58\u5728\u6218\u4e89\u5bf9CTs\u5f71\u54cd\u7684\u98ce\u9669\uff08\u771f\u5b9e\u7684\u6216\u611f\u77e5\u7684\uff09\uff0c\u8fd9\u79cd\u60c5\u51b5\u5c31\u53ef\u80fd\u7ee7\u7eed\u5b58\u5728\u3002\u7136\u800c\uff0c\u4e0e\u4fc4\u7f57\u65af\u4e0d\u540c\u7684\u662f\uff0c\u968f\u7740\u5927\u89c4\u6a21\u654c\u5bf9\u884c\u52a8\u7684\u505c\u6b62\u6216\u8fbe\u6210\u67d0\u79cd\u548c\u5e73\u534f\u8bae\uff0c\u9884\u8ba1CTs\u6d3b\u52a8\u5c06\u8fc5\u901f\u53cd\u5f39\u3002\u4ece2014\u5e74\u5360\u9886\u514b\u91cc\u7c73\u4e9a\u4ee5\u53ca\u5362\u7518\u65af\u514b\u548c\u987f\u6d85\u8328\u514b\u90e8\u5206\u5730\u533a\u7684\u7ecf\u9a8c\u8868\u660e\uff0c\u751f\u7269\u5236\u836f\u548cCRO\u80fd\u591f\u8fc5\u901f\u9002\u5e94\u53d8\u5316\u7684\u5f62\u52bf\uff0c\u5e76\u5728\u4e4c\u514b\u5170\u8fdb\u884c\u65b0\u7684\u8bd5\u9a8c\uff0c\u4e4c\u514b\u5170\u5df2\u88ab\u8bc1\u660e\u662f\u56fd\u9645iCTs\u7684\u53ef\u9760\u52a8\u529b\u6765\u6e90\u3002<\/p>\n

\u9664\u4e86\u5bf9\u4fc4\u7f57\u65af\u548c\u4e4c\u514b\u5170\u7684\u4e25\u91cd\u548c\u76f4\u63a5\u5f71\u54cd\u5916\uff0c\u6240\u6709\u5927\u578b\u7684\u5236\u836f\u516c\u53f8\u3001\u4ee5\u53ca\u5927\u578b\u548c\u4e2d\u578bCRO\u548c\u5176\u4ed6\u4e34\u5e8a\u8bd5\u9a8c\u670d\u52a1\u63d0\u4f9b\u5546\u90fd\u6536\u5230\u4e86\u6ce2\u53ca\uff0c\u4ed6\u4eec\u5fc5\u987b\u786e\u4fdd\u5168\u7403\u8303\u56f4\u5185\u7684\u987a\u5229\u4ea4\u4ed8\uff0c\u5e76\u5c3d\u91cf\u51cf\u5c11\u4e2d\u65ad\u3001\u5ef6\u8fdf\u6216\u5927\u91cf\u9884\u7b97\u8d85\u652f\u7684\u60c5\u51b5\u53d1\u751f\u3002<\/p>\n

\u5bf9\u5168\u7403\u4e34\u5e8a\u8bd5\u9a8c\u7684\u5f71\u54cd\uff1a<\/strong><\/p>\n

\u5168\u7403iCT\u884c\u4e1a\u9700\u8981\u8ba1\u5212\u6bcf\u5e74\u5728\u4fc4\u7f57\u65af\u548c\u4e4c\u514b\u5170\u4e4b\u5916\u91cd\u65b0\u5206\u914d\u8fd13.5%\u7684\u5168\u7403iCT\u7ad9\u70b9\u548c\u8fd15%\u7684iCT[v]<\/a>\u60a3\u8005\u3002\u6211\u4eec\u8ba4\u4e3a\uff0c\u4e2d\u6b27\u548c\u4e1c\u6b27\u56fd\u5bb6\uff08\u6ce2\u5170\u3001\u6377\u514b\u5171\u548c\u56fd\u3001\u5308\u7259\u5229\u3001\u65af\u6d1b\u4f10\u514b\u3001\u514b\u7f57\u5730\u4e9a\u3001\u585e\u5c14\u7ef4\u4e9a\u3001\u4fdd\u52a0\u5229\u4e9a\u3001\u7f57\u9a6c\u5c3c\u4e9a\u3001\u62c9\u8131\u7ef4\u4e9a\u3001\u7acb\u9676\u5b9b\u3001\u7231\u6c99\u5c3c\u4e9a\uff09\u6700\u6709\u6761\u4ef6\u63d0\u4f9b\u5168\u90e8\u6216\u5927\u90e8\u5206\u7684\u884c\u4e1a\u7ba1\u9053\uff0c\u8fd9\u4e9b\u7ba1\u9053\u9762\u4e34\u7740\u7269\u6d41\u8def\u7ebf\u63a5\u8fd1\u3001\u6210\u672c\u76f8\u5f53\u3001\u573a\u5730\u751f\u4ea7\u529b\u4ee5\u53ca\u4e34\u5e8a\u8bd5\u9a8c\u80fd\u529b\u5229\u7528\u4e0d\u8db3\u7b49\u72ec\u7279\u7ec4\u5408\u7684\u98ce\u9669\u3002<\/p>\n

\u5982\u679c\u60a8\u60f3\u4e86\u89e3\u66f4\u591a\uff0c\u8bf7\u70b9\u51fb9\u6708\u4efd\u7684\u300aClinical Leader<\/a>\u300b\u6742\u5fd7\u3002[vi]<\/a><\/p>\n

\u5173\u4e8eMisik\u535a\u58eb<\/strong><\/p>\n

Misik\u535a\u58eb\u5728\u4e54\u6cbb\u534e\u76db\u987f\u5927\u5b66\u533b\u5b66\u9662\u548c\u9a6c\u91cc\u5170\u5dde\u8d1d\u585e\u65af\u8fbe\u7684\u56fd\u5bb6\u764c\u75c7\u7814\u7a76\u6240\u6709\u8d85\u8fc730\u5e74\u7684\u533b\u836f\u7814\u53d1\u5de5\u4f5c\u7ecf\u9a8c\u3002\u9664\u4e86\u5728\u8de8\u56fdCRO\u516c\u53f8\u62c5\u4efb\u591a\u4e2a\u884c\u653f\u804c\u52a1\u5916\uff0cMisik\u535a\u58eb\u8fd8\u521b\u529e\u4e86LongTaal\u516c\u53f8\uff0c\u5e76\u4e14\u5229\u7528LongTaal CT\u5206\u6790\u5e73\u53f0\uff0c\u63a8\u51fa\u4e86\u5168\u7403\u7b2c\u4e00\u4e2a\u56fd\u5bb6\u7ea7\u4e34\u5e8a\u8bd5\u9a8c\u58f0\u8a89\u6307\u6570\u3002<\/a><\/p>\n

\u6570\u636e\u6765\u6e90\uff1a<\/p>\n

[i]<\/a> Castaneda R. Clinical trials in Russia: drug development pipeline at risk. Clinical Trials Arena, March 7, 2022, downloaded on May 26, 2022. [Online] https:\/\/www.clinicaltrialsarena.com\/special-focus\/ukraine-crisis\/clinical-trials-in-russia-at-risk\/<\/a>.<\/p>\n

Castaneda R. Clinical trials in Russia: big pharma makesmoves but what\u2019s the pipeline impact?; Clinical Trials Arena, March 24, 2022, dowloaded on May 26, 2022. [Online] https:\/\/www.clinicaltrialsarena.com\/analysis\/clinical-trials-in-russia-big-pharma-makes-moves\/<\/a>.<\/p>\n

Castaneda R; As Russia\u2019s clinical trials sector falls, Ukraine rebuilds. Clinical Trials Arena; August 23, 2022. [Online] https:\/\/www.clinicaltrialsarena.com\/special-focus\/ukraine-crisis\/russia-clinical-trials-fall-ukraine-rebuilds\/<\/a>.<\/p>\n

[ii]<\/a> Misik V; The Impact Of The Russia-Ukraine War On Clinical Trials. Clinical Leader; September 7, 2022. [Online] https:\/\/www.clinicalleader.com\/doc\/the-impact-of-the-russia-ukraine-war-on-clinical-trials-0001.<\/p>\n

[iii]<\/a> Misik V, Jarosz B, Beckowski L, Czarnecka M, Dabrowski T, Drake D, Milowska K, Ziecik P, Magielski P, Szczepannik W: REPORT: Industry Clinical Trials in Poland. Possibilities to increase number and scope of trials in Poland. Publishers: INFARMA and POLCRO. December 2021; pp 1-115. [Online] https:\/\/www.infarma.pl\/raporty\/raporty-infarmy\/raport-%E2%80%9Ekomercyjne-badania-kliniczne-w-polsce.-mozliwo%C5%9Bc-zwiekszania-liczby-i-zakresu-badan-klinicznych-w-polsce\/.<\/p>\n

[iv]<\/a> Dyer O. BMJ 2022;326:o745. Essential medicines keep flowing to Russia, but sanctions could severely effect health. https:\/\/www.bmj.com\/content\/376\/bmj.o745.full<\/a>.<\/p>\n

GlobalData Healthcare. Sanctions hit Russian investors with limited impact on foreign innovator drugs. Pharmaceutical Technology 28 Mar 2022. https:\/\/www.pharmaceutical-technology.com\/comment\/sanctions-russia-foreign-innovator-drugs\/<\/a>.<\/p>\n

Mulero A. Ukraine-Russia war pushes big pharma into mixed response. HealthLeaders 23Mar2022 https:\/\/www.healthleadersmedia.com\/pharma\/ukraine-russia-war-pushes-big-pharma-mixed-response.<\/p>\n

[v]<\/a> Castaneda R; As Russia\u2019s clinical trials sector falls, Ukraine rebuilds. Clinical Trials Arena; August 23, 2022. [Online] https:\/\/www.clinicaltrialsarena.com\/special-focus\/ukraine-crisis\/russia-clinical-trials-fall-ukraine-rebuilds\/.<\/p>\n

[vi]<\/a> Misik V; The Impact Of The Russia-Ukraine War On Clinical Trials. Clinical Leader; September 7, 2022. [Online] https:\/\/www.clinicalleader.com\/doc\/the-impact-of-the-russia-ukraine-war-on-clinical-trials-0001<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

\u4e34\u5e8a\u8bd5\u9a8c\u7cfb\u5217\u7531LongTaal\u516c\u53f8\u521b\u59cb\u4eba\u3001CSOFT\u5168\u7403\u4e34\u5e8a\u6218\u7565\u526f\u603b\u88c1Vladimir Misik\u535a\u58eb\u521b\u529e\u3002 […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false},"categories":[953,368,780,781,1305,1088,754,239],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/lifesciences.csoftintl.com\/zh-hans\/wp-json\/wp\/v2\/posts\/187151"}],"collection":[{"href":"https:\/\/lifesciences.csoftintl.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifesciences.csoftintl.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifesciences.csoftintl.com\/zh-hans\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/lifesciences.csoftintl.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=187151"}],"version-history":[{"count":2,"href":"https:\/\/lifesciences.csoftintl.com\/zh-hans\/wp-json\/wp\/v2\/posts\/187151\/revisions"}],"predecessor-version":[{"id":187156,"href":"https:\/\/lifesciences.csoftintl.com\/zh-hans\/wp-json\/wp\/v2\/posts\/187151\/revisions\/187156"}],"wp:attachment":[{"href":"https:\/\/lifesciences.csoftintl.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=187151"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifesciences.csoftintl.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=187151"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifesciences.csoftintl.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=187151"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}